Evidence map›Paper›PMID 19358706›Full record

ArticleBMC biochemistry2009

Identification of distinct SET/TAF-Ibeta domains required for core histone binding and quantitative characterisation of the interaction.

Zoe Karetsou, Anastasia Emmanouilidou, Ioannis Sanidas, Stamatis Liokatis, Eleni Nikolakaki, Anastasia S Politou, Thomais Papamarcaki

Open access · hybridAbstract read
In one paragraph

Article in BMC biochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. CytochromeiScience · 2024
    Article
  3. The next decade of SET: from an oncoprotein to beyond.Journal of molecular cell biology · 2024
    Review
  4. The SET oncoprotein promotes estrogen-induced transcription by facilitating establishment of active chromatin.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Review
  6. PP2A is activated by cytochromeComputational and structural biotechnology journal · 2022
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. The NMR-based characterization of the FTY720-SET complex reveals an alternative mechanism for the attenuation of the inhibitory SET-PP2A interaction.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  12. Article
  13. Development and identification of Set transgenic mice.Experimental and therapeutic medicine · 2018
    Article
  14. Article
  15. Article
  16. Structural basis for inhibition of the histone chaperone activity of SET/TAF-Iβ by cytochrome c.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Zoe KaretsouLaboratory of Biological Chemistry, Medical School, University of Ioannina, 451 10 Ioannina, Greece. zkarets@cc.uoi.gr
Anastasia Emmanouilidou
Ioannis Sanidas
Stamatis Liokatis
Eleni Nikolakaki
Anastasia S Politou
Thomais Papamarcaki
University of Ioannina · GRAristotle University of Thessaloniki · GRFoundation for Research and Technology Hellas · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe assembly of nucleosomes to higher-order chromatin structures is finely tuned by the relative affinities of histones for chaperones and nucleosomal binding sites. The myeloid leukaemia protein SET/TAF-Ibeta belongs to the NAP1 family of histone chaperones and participates in several chromatin-based mechanisms, such as chromatin assembly, nucleosome reorganisation and transcriptional activation. To better understand the histone chaperone function of SET/TAF-Ibeta, we designed several SET/TAF-Ibeta truncations, examined their structural integrity by circular Dichroism and assessed qualitatively and quantitatively the histone binding properties of wild-type protein and mutant forms using GST-pull down experiments and fluorescence spectroscopy-based binding assays.

resultsWild type SET/TAF-Ibeta binds to histones H2B and H3 with Kd values of 2.87 and 0.15 microM, respectively. The preferential binding of SET/TAF-Ibeta to histone H3 is mediated by its central region and the globular part of H3. On the contrary, the acidic C-terminal tail and the amino-terminal dimerisation domain of SET/TAF-Ibeta, as well as the H3 amino-terminal tail, are dispensable for this interaction.

conclusionThis type of analysis allowed us to assess the relative affinities of SET/TAF-Ibeta for different histones and identify the domains of the protein required for effective histone recognition. Our findings are consistent with recent structural studies of SET/TAF-Ibeta and can be valuable to understand the role of SET/TAF-Ibeta in chromatin function.

Indexed as

Amino Acid SequenceChromatinChromosomal Proteins, Non-HistoneCircular DichroismDNA-Binding ProteinsHistone ChaperonesHistonesMolecular ChaperonesMolecular Sequence DataMutant ProteinsProtein BindingProtein Structure, TertiaryRecombinant ProteinsSpectrometry, FluorescenceTranscription FactorsChromatinChromosomal Proteins, Non-HistoneDNA-Binding ProteinsHistone ChaperonesHistonesMolecular ChaperonesMutant ProteinsRecombinant ProteinsSET protein, humanTranscription Factors

Identifiers

PMID19358706
PMCPMC2676315
OpenAlexW2068683302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.